<?xml version="1.0" encoding="UTF-8"?>
<p>One recent report described an unusual mechanism of MERS-CoV-infection enhancement in vitro, whereby the antibody binding to the S protein RBD promoted endocytic uptake by engaging with an Fc-receptor and triggered fusion by inducing a conformational change (
 <xref rid="bib41" ref-type="bibr">Jaume et al., 2011</xref>). It augurs well for vaccine development, however, that a SARS-CoV-2 RBD used as an immunogen elicited strong NAb responses in rats, without any ADE (
 <xref rid="bib59" ref-type="bibr">Quinlan et al., 2020</xref>). These topics will, no doubt, be investigated thoroughly as much-needed SARS-CoV-2 vaccines undergo pre-clinical and clinical testing.
</p>
